Filing Details
- Accession Number:
- 0001213900-21-029170
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-25 20:03:19
- Reporting Period:
- 2021-05-25
- Accepted Time:
- 2021-05-25 20:03:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1726711 | Aditx Therapeutics Inc. | ADTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1527535 | Corinne Pankovcin | C/O Aditx Therapeutics, Inc. 2569 Wyandotte St., Suite 101 Mountain View CA 94043 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-25 | 4,220 | $2.56 | 114,220 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
